Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 known ✓ | Q9H244 | 1/20 | 0.32 |
| ▸ | EIF2AK2 | P19525 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | PTPRC | P08575 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2865909 | 0.92 | HTT (0.39) | EIF2AK2P2RY12ALDH1A1L3MBTL1PTPRC | |
| SCHEMBL342135 | 0.89 | MAPT (0.35) | P2RY12ALDH1A1L3MBTL1MAPT | |
| SCHEMBL21055662 | 0.87 | ALDH1A1 (0.41) | EIF2AK2P2RY12LMNATDP1ALDH1A1 | |
| SCHEMBL5344218 | 0.84 | MEN1 (0.37) | EIF2AK2LMNATDP1ALDH1A1PTPRC | |
| SCHEMBL5344213 | 0.84 | MEN1 (0.37) | EIF2AK2LMNATDP1ALDH1A1PTPRC | |
| SCHEMBL21436655 | 0.84 | ALDH1A1 (0.41) | EIF2AK2P2RY12LMNATDP1ALDH1A1 | |
| SCHEMBL21436238 | 0.84 | ALDH1A1 (0.41) | EIF2AK2P2RY12LMNATDP1ALDH1A1 | |
| SCHEMBL22031597 | 0.81 | MEN1 (0.39) | LMNATDP1ALDH1A1L3MBTL1GAA | |
| SCHEMBL5359195 | 0.81 | EIF2AK2 (0.34) | EIF2AK2P2RY12LMNATDP1 | |
| SCHEMBL21784230 | 0.78 | GAA (0.45) | TDP1ALDH1A1L3MBTL1PTPRCGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11891757-B2 | Process for dyeing animal textile fibers comprising the use of purified synthetic food dyes | VEBACHEM S.R.L.S. (IT) | 2024-02-06 | — | — | US | claimed |
| EP-3987112-B1 | PROCESS FOR DYEING ANIMAL TEXTILE FIBERS COMPRISING THE USE OF PURIFIED SYNTHETIC FOOD DYES | VEBACHEM S R L S (IT) | 2023-08-09 | — | — | EP | claimed |
| US-20220349121-A1 | PROCESS FOR DYEING ANIMAL TEXTILE FIBERS COMPRISING THE USE OF PURIFIED SYNTHETIC FOOD DYES | VEBACHEM S.R.L.S. (IT) | 2022-11-03 | — | — | US | claimed |
| CN-114341425-A | Dyeing process for animal textile fibres comprising the use of purified synthetic food dyes | 韦巴化学有限责任公司 | 2022-04-12 | — | — | CN | claimed |
| US-20210000980-A1 | METHOD AND COMPOSITION FOR THE DETECTION OF ARTHROPODS | ARKE' S.R.L. (IT) | 2021-01-07 | — | — | US | claimed |
| EP-3752834-A1 | METHOD AND COMPOSITION FOR THE DETECTION OF ARTHROPODS | ARKE' S.r.l. (IT) | 2020-12-23 | — | — | EP | claimed |
| WO-2019159124-A1 | METHOD AND COMPOSITION FOR THE DETECTION OF ARTHROPODS | ARKE' S.R.L. (IT) | 2019-08-22 | — | — | WO | claimed |
| CN-109486471-A | Material and preparation method thereof as toy | 宁海县新佳塑料制品有限公司 | 2019-03-19 | — | — | CN | claimed |
| WO-2009134794-A1 | MATERIALS AND METHODS FOR CREATING CUSTOMIZED COMPOSITIONS HAVING A TEMPORARY VISUAL INDICATOR | MELKER RICHARD J (US) | 2009-11-05 | — | — | WO | claimed |
| EP-4678703-A1 | INKJET INK AND TABLET | Toppan Holdings Inc. (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-20260002036-A1 | INKJET INK AND TABLET | TOPPAN HOLDINGS INC. (JP) | 2026-01-01 | — | — | US | disclosed |
| US-12491157-B1 | Atomoxetine hydrochloride oral suspension and use thereof | OWP Pharmaceuticals, Inc. | 2025-12-09 | — | — | US | disclosed |
| US-12478584-B1 | Atomoxetine hydrochloride oral suspension and use thereof | OWP PHARMACEUTICALS INC (US) | 2025-11-25 | — | — | US | disclosed |
| EP-3778795-B1 | INKJET INK AND TABLET | TOPPAN PRINTING CO LTD (JP) | 2025-08-13 | — | — | EP | disclosed |
| WO-2001078671-A2 | PHASE-SEPARATED RINSE-OFF HAIR COLORING/CLEANSING PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2001-10-25 | — | — | WO | disclosed |
| WO-2001052719-A2 | DETECTION OF STROKE EVENTS USING DIFFUSE OPTICAL TOMOGRAPHY | THE GENERAL HOSPITAL CORPORATION (US) | 2001-07-26 | — | — | WO | disclosed |
| EP-1083861-A1 | HYDROUS COSMETIC OR PHARMACEUTICAL STICKS | Beiersdorf Aktiengesellschaft (DE) | 2001-03-21 | — | — | EP | disclosed |
| US-6123848-A | Ultrafiltration method for purifying water-insoluble aluminum hydrates | WARNER-JENKINSON COMPANY, INC. (US) | 2000-09-26 | — | — | US | disclosed |
| WO-1999065454-A1 | HYDROUS COSMETIC OR PHARMACEUTICAL STICKS | BEIERSDORF AG (DE) | 1999-12-23 | — | — | WO | disclosed |
| US-5015263-A | Composition for coloring skin and method | CLAIROL INCORPORATED (US) | 1991-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12491157-B1 | Atomoxetine hydrochloride oral suspension and use thereof | SLC6A4, SLC6A3, MBOAT4 | P2RY12 732/4885EIF2AK2 3758/4885LMNA 3814/4885 |
| US-12478584-B1 | Atomoxetine hydrochloride oral suspension and use thereof | SLC6A4, SLC6A3, MBOAT4 | P2RY12 732/4885EIF2AK2 3758/4885LMNA 3814/4885 |
| US-20260002036-A1 | INKJET INK AND TABLET | FLOT1, ADH1A, ADH1C | P2RY12 3927/4885EIF2AK2 3511/4885LMNA 3496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.